Veracyte, Inc.
VCYT
$26.56
-$0.13-0.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.05M | 24.14M | -9.27M | -54.04M | -68.18M |
| Total Depreciation and Amortization | 23.23M | 23.46M | 23.54M | 24.99M | 26.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.02M | 48.82M | 67.54M | 96.54M | 96.03M |
| Change in Net Operating Assets | -13.87M | -21.32M | -15.69M | -17.15M | -16.53M |
| Cash from Operations | 89.42M | 75.10M | 66.12M | 50.33M | 37.43M |
| Capital Expenditure | -10.97M | -11.29M | -9.64M | -10.20M | -11.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 5.01M | 5.01M | 5.01M | 5.01M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00M | -50.00M | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -110.97M | -56.28M | -4.63M | -5.19M | -6.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.99M | 19.99M | 18.50M | 8.59M | 8.58M |
| Repurchase of Common Stock | -16.21M | -10.59M | -8.44M | -8.71M | -8.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.50M | -4.50M | -- | -- | -- |
| Cash from Financing | -716.00K | 4.90M | 10.06M | -120.00K | 288.00K |
| Foreign Exchange rate Adjustments | -242.00K | -424.00K | 274.00K | -49.00K | 5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.51M | 23.30M | 71.83M | 44.97M | 31.63M |